Riddhi Siddhi Gluco Biols Intrinsic Value
Riddhi Siddhi Gluco Biols (RIDDHI) median intrinsic value is ₹754.29 from 8 valuation models (range ₹247–₹1992), vs current price ₹796.65 — -5.3% downside (Trading Near Calculated Value), margin of safety -5.6%. For current market price and key ratios, visit Riddhi Siddhi Gluco Biols share price today.
RIDDHI Valuation Methods Summary — DCF, Graham Number & P/E
Riddhi Siddhi Gluco Biols intrinsic value across 8 models vs current price ₹796.65 — upside/downside and value range per method. Analyse RIDDHI shareholding pattern to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹926.40 | ₹741.12 - ₹1111.68 | +16.3% | EPS: ₹77.20, Sector P/E: 12x |
| Book Value Method | asset | ₹1991.62 | ₹1792.46 - ₹2190.78 | +150.0% | Book Value/Share: ₹2267.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹246.86 | ₹222.17 - ₹271.55 | -69.0% | Revenue/Share: ₹308.57, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹754.29 | ₹678.86 - ₹829.72 | -5.3% | EBITDA: ₹88.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹318.66 | ₹254.93 - ₹382.39 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹494.08 | ₹444.67 - ₹543.49 | -38.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹636.13 | ₹572.52 - ₹699.74 | -20.1% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹1984.45 | ₹1786.01 - ₹2182.90 | +149.1% | EPS: ₹77.20, BVPS: ₹2267.14 |
RIDDHI Intrinsic Value vs Market Price — All Valuation Models
Riddhi Siddhi Gluco Biols fair value range ₹247–₹1992 vs current market price ₹796.65 across 8 valuation models. Read RIDDHI dividend yield for the complete payout history and dividend yield track record.
RIDDHI Intrinsic Value Analysis — Undervalued or Overvalued?
Riddhi Siddhi Gluco Biols median intrinsic value ₹754.29, current price ₹796.65 — Trading Near Calculated Value by 5.3%, margin of safety -5.6%.
What is the intrinsic value of RIDDHI?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Riddhi Siddhi Gluco Biols (RIDDHI) is ₹754.29 (median value). With the current market price of ₹796.65, this represents a -5.3% variance from our estimated fair value.
The valuation range spans from ₹246.86 to ₹1991.62, indicating ₹246.86 - ₹1991.62.
Is RIDDHI undervalued or overvalued?
Based on our multi-method analysis, Riddhi Siddhi Gluco Biols (RIDDHI) appears to be trading near calculated value by approximately 5.3%.
RIDDHI Financial Health — Key Ratios vs Industry Benchmarks
Riddhi Siddhi Gluco Biols financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 38.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.12x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
RIDDHI Cash Flow Quality — Operating & Free Cash Flow
Riddhi Siddhi Gluco Biols operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-28 Cr | ₹-28 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹161 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹130 Cr | ₹104 Cr | Positive Free Cash Flow | 8/10 |